Nurix Therapeutics, Inc. (NRIX)

NASDAQ: NRIX · Real-Time Price · USD

16.45

-0.26 (-1.56%)

At close: Feb 10, 2026, 4:00 PM EST

16.53

+0.08 (0.49%)

After-hours: Feb 10, 2026, 4:29 PM EST

Nurix Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is December - November.

Millions USD. Fiscal year is Dec - Nov.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Feb '26 Feb 10, 2026	Nov '25 Nov 30, 2025	Nov '24 Nov 30, 2024	Nov '23 Nov 30, 2023	Nov '22 Nov 30, 2022	Nov '21 Nov 30, 2021
Market Capitalization	1,692	1,792	1,566	302	584	1,286
Market Cap Growth	19.83%	14.43%	419.13%	-48.35%	-54.57%	-22.36%
Enterprise Value	1,155	1,420	1,136	41	184	942
Last Close Price	16.71	17.68	22.11	6.22	12.39	28.82
PS Ratio	17.24	21.34	28.71	3.92	15.12	43.22
PB Ratio	3.16	3.33	2.97	1.51	1.92	3.76
P/TBV Ratio	3.14	3.33	2.97	1.51	1.92	3.76
EV/Sales Ratio	13.75	16.91	20.82	0.53	4.76	31.66
Debt / Equity Ratio	0.10	0.10	0.05	0.15	0.04	0.04
Asset Turnover	0.12	0.12	0.11	0.20	0.09	0.07
Quick Ratio	6.87	6.87	6.38	3.32	4.39	4.57
Current Ratio	7.02	7.02	6.46	3.40	4.51	4.70
Return on Equity (ROE)	-49.63%	-49.63%	-53.22%	-57.10%	-55.84%	-37.05%
Return on Assets (ROA)	-26.30%	-26.30%	-25.98%	-25.10%	-25.72%	-16.88%
Return on Capital Employed (ROCE)	-47.50%	-47.50%	-37.10%	-57.70%	-53.10%	-28.70%
Earnings Yield	-15.63%	-14.76%	-12.36%	-47.71%	-30.88%	-9.12%
FCF Yield	-15.57%	-14.70%	-11.61%	-29.75%	-29.45%	-7.00%
Buyback Yield / Dilution	-29.12%	-29.12%	-23.52%	-11.79%	-13.32%	-173.68%

Updated Nov 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q